.
Improving Natural Glycopeptide Isolation Technology and Studying Their Immune-Modulating Properties (Stage I)
Improving Natural Glycopeptide Isolation Technology and Studying Their Immune-Modulating Properties (Stage I)
Project/agreement No.
KC-PI-2020/17
Project funding
27 778.00 EUR, including 25.000 EUR ERDF funding and 2.778 EUR RSU co-funding
Project manager
Project realization
01.04.2020. - 30.09.2020.
Aim
The project's overall objective is to improve the technology for producing natural glycopeptides.
Description
Stage I - Feasibility study and commercialisation strategy development
- Feasibility study:
- market, competitor research;
- identifying potentially interested groups (associations, industry, developers, potential users, etc.) and their views on the potential product, the need for it and the interest of potential users;
- determining the level of maturity of the product, drawing up a development plan;
- assessing the patentability of the development and determining the purity of the invention (freedom-to-operate);
- developing potential commercialisation scenarios, economic calculations.
- Partial development of a commercialisation strategy by external expertise.
